A critical breakthrough in cancer research is arising with the use of nanobodies to reactivate damaged p53. This essential tumor inhibitor protein is frequently inactivated in many kinds of malignancies, resulting https://one-bookmark.com/story21890866/nanobodies-reactivate-tumor-suppressor-p53-new-new-pathway-for-cancer-treatment